Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsOperating LeasesOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Neuroone Medical Technologies (NMTC) Accounts Payables (2016 - 2025)

Neuroone Medical Technologies' Accounts Payables history spans 12 years, with the latest figure at $552332.0 for Q4 2025.

  • For Q4 2025, Accounts Payables fell 25.81% year-over-year to $552332.0; the TTM value through Dec 2025 reached $552332.0, down 25.81%, while the annual FY2025 figure was $1.0 million, 1.83% down from the prior year.
  • Accounts Payables reached $552332.0 in Q4 2025 per NMTC's latest filing, down from $1.0 million in the prior quarter.
  • In the past five years, Accounts Payables ranged from a high of $1.0 million in Q3 2024 to a low of $296410.0 in Q2 2021.
  • Average Accounts Payables over 5 years is $702374.0, with a median of $751892.5 recorded in 2024.
  • Peak YoY movement for Accounts Payables: surged 194.99% in 2023, then crashed 38.4% in 2025.
  • A 5-year view of Accounts Payables shows it stood at $703718.0 in 2021, then increased by 22.44% to $861638.0 in 2022, then fell by 11.8% to $760000.0 in 2023, then dropped by 2.04% to $744525.0 in 2024, then dropped by 25.81% to $552332.0 in 2025.
  • Per Business Quant, the three most recent readings for NMTC's Accounts Payables are $552332.0 (Q4 2025), $1.0 million (Q3 2025), and $467734.0 (Q2 2025).